Whether these low rates of depression is caused by genetic or environmental alterations is unknown, however, the finding of CPT1a mutations in the Hutterite and Inuit population supports the novel theory in this study stating that a decreased activity of CPT1 increases resiliency for developing depression 45
and enhancement of GSH levels can be a means for treating and preventing COVID-19 disease (Polonikov, 2020)
Downsides to potential peptides ban Why you should care: If the FDA enforces a strict ban, patients managing conditions like colitis, depression, severe inflammation, and sleep disorders through custom peptide therapies could lose access to their treatments overnight
Its real-world benefit is conditional strongest in vegetarians, vegans, and physically active individuals, and weak to negligible in sedentary people with already-sufficient carnitine status